INNOVIVA, INC. Shares Issued
INNOVIVA, INC. (INVA) had Shares Issued of 72.64 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-05
- 2026-06-30: Common Stock, Shares, Issued 72.64M shares.
- 2026-03-31: Common Stock, Shares, Issued 73.81M shares.
- 2025-12-31: Common Stock, Shares, Issued 74.64M shares.
- 2025-09-30: Common Stock, Shares, Issued 74.77M shares.
| Period end | Common Stock, Shares, Issued |
|---|---|
| 2026-06-30 | 72.64M shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 73.81M shares 10-Q · filed 2026-05-06 |
| 2025-12-31 | 74.64M shares 10-Q · filed 2026-08-05 |
| 2025-09-30 | 74.77M shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 63.01M shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 62.77M shares 10-Q · filed 2025-05-07 |
| 2024-12-31 | 62.66M shares 10-K · filed 2026-02-25 |
| 2024-09-30 | 62.60M shares 10-Q · filed 2024-11-06 |
| 2024-06-30 | 62.56M shares 10-Q · filed 2024-07-31 |
| 2024-03-31 | 62.80M shares 10-Q · filed 2024-05-08 |
| 2023-12-31 | 63.31M shares 10-K · filed 2025-02-26 |
| 2023-09-30 | 64.38M shares 10-Q · filed 2023-11-01 |
| 2023-06-30 | 65.22M shares 10-Q · filed 2023-08-02 |
| 2023-03-31 | 65.82M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 69.19M shares 10-K/A · filed 2024-03-05 |
| 2022-09-30 | 69.78M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 69.71M shares 10-Q · filed 2022-07-27 |
| 2022-03-31 | 69.59M shares 10-Q · filed 2022-05-05 |
| 2021-12-31 | 69.57M shares 10-K · filed 2023-02-28 |
| 2021-09-30 | 69.49M shares 10-Q · filed 2021-10-27 |
| 2021-06-30 | 69.50M shares 10-Q · filed 2021-07-29 |
| 2021-03-31 | 101.41M shares 10-Q · filed 2021-04-28 |
| 2020-12-31 | 101.39M shares 10-K/A · filed 2022-03-17 |
| 2020-09-30 | 101.39M shares 10-Q · filed 2020-10-28 |
| 2020-06-30 | 101.39M shares 10-Q · filed 2020-07-29 |
| 2020-03-31 | 101.32M shares 10-Q · filed 2020-04-29 |
| 2019-12-31 | 101.29M shares 10-K · filed 2021-02-25 |
| 2019-09-30 | 101.28M shares 10-Q · filed 2019-10-30 |
| 2019-06-30 | 101.27M shares 10-Q · filed 2019-07-24 |
| 2019-03-31 | 101.18M shares 10-Q · filed 2019-05-01 |
| 2018-12-31 | 101.10M shares 10-K · filed 2020-02-19 |
| 2018-09-30 | 101.19M shares 10-Q · filed 2018-10-31 |
| 2018-06-30 | 101.66M shares 10-Q · filed 2018-07-26 |
| 2018-03-31 | 101.47M shares 10-Q · filed 2018-05-04 |
| 2017-12-31 | 102.05M shares 10-K · filed 2019-02-19 |
| 2017-09-30 | 108.15M shares 10-Q · filed 2017-11-03 |
| 2017-06-30 | 109.51M shares 10-Q · filed 2017-08-08 |
| 2017-03-31 | 109.35M shares 10-Q · filed 2017-05-05 |
| 2016-12-31 | 108.58M shares 10-K · filed 2018-02-23 |
| 2016-09-30 | 109.69M shares 10-Q · filed 2016-11-03 |
| 2016-06-30 | 111.62M shares 10-Q · filed 2016-08-04 |
| 2016-03-31 | 113.15M shares 10-Q · filed 2016-05-05 |
| 2015-12-31 | 114.93M shares 10-K · filed 2017-02-28 |
| 2015-09-30 | 117.58M shares 10-Q · filed 2015-11-05 |
| 2015-06-30 | 117.17M shares 10-Q · filed 2015-08-06 |
| 2015-03-31 | 116.92M shares 10-Q · filed 2015-05-08 |
| 2014-12-31 | 116.44M shares 10-K · filed 2016-02-24 |
| 2014-09-30 | 115.38M shares 10-Q · filed 2014-11-04 |
| 2013-12-31 | 111.52M shares 10-K · filed 2015-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |